Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank-Reference-Cited by-同舟云学术

Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

Published:2019-01 Issue: Volume:259 Page:54-61
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Sharafi Heidar,Maleki Saeideh^ORCID,Alavian Seyed Moayed

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference55 articles.

1. Alavian SM. Mysterious linkages between hepatitis C virus genotypes, Interleukin-28B genotypes and viral clearance- a meta-analysis;Aalaei-Andabili;Hepat. Mon.,2014

2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N. Engl. J. Med.,2014

3. Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017;Alavian;Hepat. Mon.,2017

4. Frequency of natural resistance within NS5a replication complex domain in hepatitis C genotypes 1a, 1b: possible implication of subtype-specific resistance selection in multiple direct acting antivirals drugs combination treatment;Bagaglio;Viruses,2016

5. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment;Bartels;J. Virol.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals;Frontiers in Pharmacology;2022-04-27

2. The Bank Vole (Clethrionomys glareolus)—Small Animal Model for Hepacivirus Infection;Viruses;2021-12-03

3. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection;Frontiers in Microbiology;2021-01-28

4. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study;CASP J INTERN MED;2020